COPD and osteoporosis: links, risks, and treatment challenges

Area of Science:

• Pulmonology
• Endocrinology
• Geriatrics

Background:

• Chronic obstructive pulmonary disease (COPD) is linked to systemic comorbidities, notably osteoporosis.
• Osteoporosis and fractures significantly impair quality of life and respiratory function in COPD patients.
• COPD-associated osteoporosis is frequently underdiagnosed and undertreated.

Purpose of the Study:

• To highlight the prevalence and impact of osteoporosis in COPD patients.
• To emphasize the importance of recognizing clinical risk factors for osteoporosis in this population.
• To advocate for routine osteoporosis screening in COPD patients.

Main Methods:

• Review of recent studies on bone mineral density (BMD) and bone quality in COPD.
• Identification of clinical risk factors associated with osteoporosis in COPD.
• Analysis of the impact of fractures on COPD patients' health.

Main Results:

• Decreased BMD and impaired bone quality contribute to bone fragility and fractures in COPD.
• Clinical risk factors include older age, emaciation, inactivity, and vitamin D deficiency.
• Fractures negatively affect quality of life and respiratory function.

Conclusions:

• Pulmonologists must be aware of the high prevalence of osteoporosis in COPD.
• Routine screening can facilitate early diagnosis and appropriate treatment.
• Timely intervention can prevent fractures, improving quality of life and prognosis.